Indefinite Delivery Contract SPE2DB24D9241

The key points are as follows:

This is an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The single-award IDC has a ceiling value of $499,999,999 and runs through December 31, 2025.

Under this IDC, DMS Pharmaceutical Group Inc. will provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities worldwide. This includes branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. Specific products supplied encompass items such as flumazenil injections, prednisone tablets, ampicillin injections, clotrimazole cream, epinephrine auto-injectors, contraceptives, oncology drugs, and specialty medications. The contract covers both routine and critical medications to address the diverse medical requirements of DoD personnel and their dependents. Delivery orders issued under the IDC are firm fixed-price, with no set-aside designations. This IDC complements DMS Pharmaceutical Group's existing prime vendor contracts for direct pharmaceutical distribution to DoD sites, solidifying its position as a key supplier in the federal pharmaceutical supply chain.